Sinusitis: New practice parameter tackles antimicrobial use

Most upper respiratory infections that you see in the office are viral; treating them with antibiotics is, of course, pointless. Sinusitis is a different kettle of fish, however: It causes more discomfort than a run-of-the-mill cold, lasts longer, is often bacterial, and is properly treated with antibiotics.

So that is the quandary: Is antibiotic treatment for a patient whose symptoms might be sinusitis a reasonable choice or just an injudicious use of antibiotics? An updated sinusitis practice parameter from the American Academy of Allergy, Asthma, and Immunology (AAAAI) offers some guidance:

The full text of the practice parameter is in the December 2005 issue of the Journal of Allergy and Clinical Immunology (also at http://www.jacionline.org/).

Related Videos
Benjamin Maxwell, MD, chief of child and adolescent psychiatry, Rady Children’s Hospital, San Diego, California | Image provided
FDA approves B-VEC to treat dystrophic epidermolysis bullosa patients 6 months and older | Image Credit: bankrx - Image Credit: bankrx - stock.adobe.com.
Pfizer's infant RSV vaccine receives FDA Advisory Committee's support | Image Credit: Dr_Microbe - Image Credit: Dr_Microbe
Thomas R. Young, MD | Image Credit: Author provided
J. Thomas Megerian, MD, PhD, FAAP | Author provided
© 2023 MJH Life Sciences

All rights reserved.